NSRX CIK: 2029039

Nasus Pharma Ltd

  • Israel
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
billions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
0
(positive)
Change from FY22 to FY25
billions USD
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
0.00
(positive)
Change from FY22 to FY24
billions USD
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
–
(positive)
Change from FY22 to FY24
billions USD
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
–
(positive)
Change from FY22 to FY25
billions USD
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
−0.01

All amounts in billions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data